The analysis of hepatitis C treatment with peginterferon alfa 2b and ribavirin in three regional hospitals in Taiwan
碩士 === 高雄醫學大學 === 藥學研究所碩士在職專班 === 94 === Background: Chronic hepatitis C virus (HCV) infection affects 170 million people worldwide. The prevalence of chronic hepatitis C is 2% to 5% in Taiwan, but 20-60% in some areas. The optimal therapeutic regimen for hepatitis C is pegylated interferon in combi...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2006
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/84910107206325271259 |